HGF and cardiovascular disorder: Attempts to use single paracrine factors, such as beta fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF), to treat cardiovascular diseases so far have shown unsatisfactory outcomes, demonstrating that these factors alone are not sufficient to induce regeneration [52].